Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-198X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome ; day:18 ; month:12 ; year:2018 ; pages:1-9
Pediatric nephrology ; (18.12.2018), 1-9
- Urheber
-
Maxted, Andrew P.
Dalrymple, Rebecca A.
Chisholm, Denise
McColl, John
Tse, Yincent
Christian, Martin T.
Reynolds, Ben C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00467-018-4172-3
- URN
-
urn:nbn:de:101:1-2019020620575144107224
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maxted, Andrew P.
- Dalrymple, Rebecca A.
- Chisholm, Denise
- McColl, John
- Tse, Yincent
- Christian, Martin T.
- Reynolds, Ben C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rituximab for nephrotic syndrome in children
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse
Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Correction: Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital
Rituximab for nephrotic syndrome in children
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse
Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Correction: Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital
Rituximab for nephrotic syndrome in children
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse
Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
Correction: Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies